Diagnostic value of combined assessment of olfaction and substantia nigra hyperechogenicity for Parkinson's disease

Diagnostic value of combined assessment of olfaction and substantia nigra hyperechogenicity for Parkinson's disease

Introduction: Hyposmia and substantia nigra hyperechogenicity (SN+) are characteristic markers of Parkinson's disease (PD), although their diagnostic value in isolation may be limited. We evaluated the combined prevalence of both disorders in patients diagnosed with PD and assessed their diagno...

Full description

Bibliographic Details
Main Authors:	N. López Hernández, A. García Escrivá, M. Shalabi Benavent
Format:	Article
Language:	English
Published:	Elsevier España 2015-10-01
Series:	Neurología (English Edition)
Online Access:	http://www.sciencedirect.com/science/article/pii/S2173580815001169

Similar Items

Cognitive performance patterns in healthy individuals with substantia nigra hyperechogenicity and early Parkinson’s disease
by: Rezzak Yilmaz, et al.
Published: (2016-11-01)

Hyperechogenicity of the Substantia Nigra in Parkinson’s Disease: Insights from Two Brothers with Markedly Different Disease Durations
by: Julie M. Hall, et al.
Published: (2017-01-01)

Advancements in understanding substantia nigra hyperechogenicity via transcranial sonography in Parkinson’s disease and its clinical implications
by: Yuan-yuan Zhang, et al.
Published: (2024-07-01)

Clinical Features in Parkinson’s Disease Patients with Hyperechogenicity in Substantia Nigra: A Cross-Sectional Study
by: Zhu S, et al.
Published: (2022-08-01)

Substantia nigra hyperechogenicity and brain ventricular size as biomarkers of early dementia with Lewy bodies
by: Anna Planas-Ballvé, et al.
Published: (2024-10-01)

Usefulness of Cardiac MIBG Scintigraphy, Olfactory Testing and Substantia Nigra Hyperechogenicity as Additional Diagnostic Markers for Distinguishing between Parkinson's Disease and Atypical Parkinsonian Syndromes.
by: Hiroaki Fujita, et al.
Published: (2016-01-01)

Diagnostic utility of 7T neuromelanin imaging of the substantia nigra in Parkinson’s disease
by: Dhairya A. Lakhani, et al.
Published: (2024-01-01)

Substantia nigra alterations in mice modeling Parkinson’s disease
by: I. N. Rozhkova, et al.
Published: (2024-11-01)

Explorative Combined Lipid and Transcriptomic Profiling of Substantia Nigra and Putamen in Parkinson’s Disease
by: Helena Xicoy, et al.
Published: (2020-08-01)

Sex-Related Abnormalities in Substantia Nigra Lipids in Parkinson’s Disease
by: T. N. Seyfried, et al.
Published: (2018-06-01)

Imaging of Substantia Nigra in Parkinson’s Disease: A Narrative Review
by: Paola Feraco, et al.
Published: (2021-06-01)

Classification of Parkinson’s Disease in Patch-Based MRI of Substantia Nigra
by: Sayyed Shahid Hussain, et al.
Published: (2023-08-01)

Ferroptosis-related factors in the substantia nigra are associated with Parkinson’s disease
by: Lei Liu, et al.
Published: (2023-09-01)

Application value of multiparametric MRI for evaluating iron deposition in the substantia nigra in Parkinson's disease
by: Qing Cao, et al.
Published: (2023-01-01)

Eyes as Gateways for Environmental Light to the Substantia Nigra: Relevance in Parkinson’s Disease
by: Stefania Romeo, et al.
Published: (2014-01-01)

MRI characteristics of the substantia nigra in Parkinson's disease: a combined quantitative T1 and DTI study.
by: Menke, R, et al.
Published: (2009)

Impact of Combined Subthalamic Nucleus and Substantia Nigra Stimulation on Neuropsychiatric Symptoms in Parkinson’s Disease Patients
by: U. Hidding, et al.
Published: (2017-01-01)

Connectivity-based segmentation of the substantia Nigra in human and its implications in Parkinson's disease.
by: Menke, R, et al.
Published: (2010)

Connectivity-based segmentation of the substantia nigra in human and its implications in Parkinson's disease.
by: Menke, R, et al.
Published: (2010)

Ultrastructural localization of Porphyromonas gingivalis gingipains in the substantia nigra of Parkinson’s disease brains
by: Florian Ermini, et al.
Published: (2024-04-01)

Neuroprotective Effect of Ghrelin on Substantia Nigra in Parkinson Disease Model Induced -MPTP
by: Neda Nikoklam Nazif
Published: (2019-10-01)

The role of substantia nigra sonography in the differentiation of Parkinson’s disease and multiple system atrophy
by: Hai-Yan Zhou, et al.
Published: (2018-07-01)

Utility of Combining Transcranial Sonography and MIBG Myocardial Scintigraphy to Evaluate Substantia Nigra in Patients with Parkinson’s Disease
by: Heisuke Mizukami, et al.
Published: (2024-05-01)

The application value of quantitative susceptibility mapping in evaluating substantia nigra "swallow tail sign" in the diagnosis of Parkinson's disease
by: Xiao-jun GUAN, et al.
Published: (2018-04-01)

Altered expression of genes involved in ganglioside biosynthesis in substantia nigra neurons in Parkinson's disease.
by: Jay S Schneider
Published: (2018-01-01)

Substantia Nigra Echogenicity Signal Correlated with Clinical Features in Patients with Parkinson’s Disease in Xinjiang
by: Rurui Wei, et al.
Published: (2023-01-01)

Intense exercise increases dopamine transporter and neuromelanin concentrations in the substantia nigra in Parkinson’s disease
by: Bart de Laat, et al.
Published: (2024-02-01)

Dopaminergic neurodegeneration in the substantia nigra is associated with olfactory dysfunction in mice models of Parkinson’s disease
by: Yu Yuan, et al.
Published: (2023-10-01)

Stereotaxic Injection of LPS into Mouse Substantia Nigra
by: Huiming Gao
Published: (2012-04-01)

COMPARISON OF LOCUS COERULEUS PATHOLOGY WITH SUBSTANTIA NIGRA PATHOLOGY IN A PROGRESSIVE MONKEY MODEL OF PARKINSON'S DISEASE
by: Megan Carrillo Díaz De Argandoña, et al.
Published: (2023-10-01)

Valor de la evaluación combinada de olfación e hiperecogenicidad de sustancia negra en el diagnóstico de la enfermedad de Parkinson
by: N. López Hernández, et al.
Published: (2015-10-01)

Nanoscale synchrotron x-ray analysis of intranuclear iron in melanised neurons of Parkinson’s substantia nigra
by: Jake Brooks, et al.
Published: (2024-08-01)

Neuromelanin magnetic resonance imaging of substantia nigra and locus coeruleus in Parkinson’s disease with freezing of gait
by: Shangpei Wang, et al.
Published: (2023-02-01)

Salivary gland immunohistochemistry vs substantia nigra sonography: comparative analysis of diagnostic significance
by: Kristina K. Khacheva, et al.
Published: (2023-03-01)

Identification of Hub Genes and Potential Molecular Pathogenesis in Substantia Nigra in Parkinson’s Disease via Bioinformatics Analysis
by: Yunan Zhou, et al.
Published: (2023-01-01)

Integrative analysis of gene expression profiles of substantia nigra identifies potential diagnosis biomarkers in Parkinson's disease
by: Junming Huang, et al.
Published: (2024-01-01)

Proteomic Characterization of Synaptosomes from Human Substantia Nigra Indicates Altered Mitochondrial Translation in Parkinson’s Disease
by: Sarah Plum, et al.
Published: (2020-12-01)

Picornavirus May Be Linked to Parkinson’s Disease through Viral Antigen in Dopamine-Containing Neurons of Substantia Nigra
by: Bo Niklasson, et al.
Published: (2022-03-01)

Locus coeruleus and substantia nigra neuromelanin magnetic resonance imaging differentiates Parkinson’s disease and essential tremor
by: Xinhui Wang, et al.
Published: (2023-01-01)

Behavioral effects of aminochrome and dopachrome injected in the rat substantia nigra.
by: Díaz-Véliz, G, et al.
Published: (2002)